Iain D. Dukes is Director of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 54,000 shares of IOVA, which is worth approximately $439,560. The most recent transaction as insider was on Feb 20, 2024, when has been sold 32,000 shares (Common Stock) at a price of $9.15 per share, resulting in proceeds of $292,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54K
0% 3M change
145.45% 12M change
Total Value Held $439,560

Iain D. Dukes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Open market or private purchase
$292,800 $9.15 p/Share
32,000 Added 37.21%
54,000 Common Stock
Nov 23 2022
BUY
Open market or private purchase
$61,000 $6.1 p/Share
10,000 Added 31.25%
22,000 Common Stock

Also insider at

THRX
Theseus Pharmaceuticals, Inc. Healthcare
IKNA
Ikena Oncology, Inc. Healthcare
ONTX
Onconova Therapeutics, Inc. Healthcare
IDD

Iain D. Dukes

Director
San Carlos, CA

Track Institutional and Insider Activities on IOVA

Follow IOVANCE BIOTHERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA